Southern Research Institute's Neurodegenerative Disease Drug Discovery Program Receives National Institute of Mental Heal...(techniques tools and eventually safe and...),Health

Funding will be provided by National Institute of Mental Health. The National Institute of Neurological Disorders and Stroke donated the 108,000 compound collection which was selected by Southern Research medicinal chemists for the Institute high throughput screening program in neurodegenerative disorders. This project is also part of the NIH's Molecular Libraries Roadmap Initiative - an effort to broaden access to high throughput robotic assay technologies and facilitate the creation of a public database of small molecules and their biological effects. Southern Research participates in the Roadmap Initiative as a member of the Molecular Libraries Screening Centers Network (MLSCN). NIH's funding of MLSCN supports a research network that uses robotic HTS methods to identify small molecule probes as tools for drug discovery, and has helped enable Southern Research to incorporate the most advanced HTS and imaging technologies into its laboratories that are integral to drug discovery.

About Southern Research

Southern Research Institute is an independent 501-(c)-3, not-for-profit center for scientific research. Founded in 1941, Southern Research is known for innovative leadership in major scientific discoveries in drug discovery and development, aerospace and materials engineering, and environment and energy research. Public and private sector clients include the National Institutes of Health, U.S. Departments of Justice, Defense, Energy, Environmental Protection Agency and NASA, as well as major private companies in pharmaceutical, biotechnology, energy, manufacturing and more. For more information visit http://www.southernresearch.org.

CONTACT: Rhonda Jung of Southern Research Institute, +1-205-581-2317, Jung@southernresearch.org and Risa B
'/>"/>